Industries > Pharma > Global Vaccine Contract Manufacturing Market Report 2019-2029

Global Vaccine Contract Manufacturing Market Report 2019-2029

Paediatric Vaccines, Adult Vaccines, Influenza Vaccines, Therapeutic Vaccines, Downstream Processing, Fill & Finish Operations, Analytical & QC Studies, Packaging, Upstream Processing, Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing

PUBLISHED: 02 April 2019
PAGES: 217
PRODUCT CODE: PHA0383

Clear
WOOCS 2.2.1

The global vaccine contract manufacturing market was worth $1.9bn in 2018 and is expected to grow at a CAGR of 9.3% from 2019-2023. In 2018, the paediatric vaccines segment held 48% of the global vaccine contract manufacturing market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 217-page report you will receive 80 tables and 57 figures– all unavailable elsewhere.

The 217-page report provides clear detailed insight into the global vaccine contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Revenue and growth forecasts from 2019 to 2029 for the global vaccine market

• Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market

• Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market by type:
• Paediatric Vaccines
• Adult Vaccines
• Influenza Vaccines
• Therapeutic Vaccines

• Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market by workflow:
• Downstream Processing: the revenues are further broken down into Fill & Finish Operations, Analytical & QC Studies, Packaging
• Upstream Processing: the revenues are further broken down into Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing

• Revenue and growth forecasts from 2019 to 2029 for the leading regional and national markets:
• North America: the revenues are further broken down into the US and Canada
• Europe: the revenues are further broken down into the UK, Germany, France, Italy and Spain
• Asia-Pacific: the revenues are further broken down into China, Japan and India
• Rest of the World: the revenues are further broken down into Brazil, Mexico, Russia and South Africa

Global Vaccine Contract Manufacturing Market Report 2019-2029

The regional markets are further broken down by type and workflow.

• Discussion and profiles of the leading players in the vaccine contract manufacturing market:
• AbbVie
• Baxter BioPharma Solutions
• Boehringer Ingelheim
• Catalent
• Charles River Laboratories
• Evonik Degusa
• IDT Biologika
• Lonza
• Meridian Life Science
• Nipro Corporation
• Pfizer CentreOne
• Sigma Aldrich Fine Chemicals
• SynCo Bio Partners
• Vetter Pharmaceutical

• A SWOT analysis discussing the industry trends, strengths, weaknesses, opportunities and threats.

• Discussion on vaccine manufacturing technologies covering new substrates for vaccine production, next-generation expression systems and vectors, equipment trends, pre-filled syringes and vaccines, lyophilization and vaccine manufacturing, cell-based techniques.

• Key Questions Answered by this Report:
• How is the vaccine contract manufacturing market evolving?
• What is driving and restraining the vaccine contract manufacturing market?
• What are the market shares of the leading segments of the vaccine contract manufacturing market in 2018?
• What is the value of the leading sectors in important regions of the world?
• What will be the main driver of the overall market from 2019 to 2029?
• How will political and regulatory factors influence the regional markets and submarkets?
• Will leading national vaccine contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the leading national markets change by 2029 and which country will lead the market in 2029?
• How will the industry evolve during the period between 2019 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the global vaccine contract manufacturing market. You find data, trends and predictions.

Buy our report today Global Vaccine Contract Manufacturing Market Analysis : Paediatric Vaccines, Adult Vaccines, Influenza Vaccines, Therapeutic Vaccines, Downstream Processing, Fill & Finish Operations, Analytical & QC Studies, Packaging, Upstream Processing, Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2019-2029


Latest Pharma news

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021

READ

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Categories